Even in Denmark — Novo Nordisk's property market — an application for Wegovy to get public overall health insurance coverage coverage was turned down on the grounds that its cost was incommensurate with its therapeutic worth.Our digital approach to healthcare involves every thing from prognosis to crafting prescriptions — and delivering medic